Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “COVID19 Vaccination”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT05499299
What this trial is testing

Volatility and Heterogeneity of Vaccine Sentiments Means Continuous Monitoring is Needed When Measuring Message Effectiveness

Who this might be right for
Vaccine-Preventable DiseasesVaccine Refusal
The University of Hong Kong 127,000
Not applicableUnknownNCT05043272
What this trial is testing

Safety and Immune Response of COVID-19 Vaccination in Overweight People With Excessive BMI

Who this might be right for
Covid19Overweight
The Second Affiliated Hospital of Chongqing Medical University 450
Not applicableUnknownNCT05009134
What this trial is testing

Influences of Allergic Rhinitis and Allergen Immunotherapy on SARS-CoV-2 Vaccination

Who this might be right for
Allergic RhinitisAllergen ImmunotherapySARS-CoV-2
Huazhong University of Science and Technology 120
Large-scale testing (Phase 3)Study completedNCT05715944
What this trial is testing

Incidence of COVID-19 Following Vaccination in Botswana Against SARS CoV 2

Who this might be right for
COVID-19
Botswana Harvard AIDS Institute Partnership 10,888
Large-scale testing (Phase 3)UnknownNCT05664932
What this trial is testing

Immunogenicity and Safety of COVID-19 Vaccine as a Booster Vaccination in Population Aged 18 Years and Above

Who this might be right for
COVID-19
Guangzhou Patronus Biotech Co., Ltd. 1,200
Not applicableStudy completedNCT04751734
What this trial is testing

Impact of Maternal COVID-19 Vaccines on Breast Milk

Who this might be right for
COVID-19 Vaccines
Institute of Agrochemistry and Food Technology, National Research Council 120
Post-approval studies (Phase 4)UnknownNCT05373030
What this trial is testing

Sequential Immunization With Recombinant Adenovirus Type-5-vectored COVID-19 Vaccine in Health Adults Based on 3 Doses Inactivated COVID-19 Vaccine

Who this might be right for
Immunogenicity and Safety of a Recombinant Adenovirus Type-5-vectored COVID-19 Vaccine Using for Sequential Immunization
Zhejiang Provincial Center for Disease Control and Prevention 200
Early research (Phase 1)Study completedNCT05477186
What this trial is testing

Safety and Immunogenicity Study of a Booster Dose of the Investigational CV0501 mRNA COVID-19 Vaccine in Adults at Least 18 Years Old

Who this might be right for
COVID-19SARS-CoV-2
GlaxoSmithKline 185
Not applicableStudy completedNCT05729191
What this trial is testing

Evaluation of the Acceptance of the Anti-COVID-19 Vaccine Offer Among Pregnant Women

Who this might be right for
Pregnant WomenCOVID 19 VaccineVaccination Hesitancy
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 100
Not applicableStudy completedNCT05612373
What this trial is testing

Message Offering Free Round Trip Ride-Share Ride to Pharmacy

Who this might be right for
COVID-19
University of Pennsylvania 300,000
Post-approval studies (Phase 4)Study completedNCT04892459
What this trial is testing

Study on Sequential Immunization of Inactivated SARS-CoV-2 Vaccine and Recombinant SARS-CoV-2 Vaccine (Ad5 Vector)

Who this might be right for
COVID-19
Jiangsu Province Centers for Disease Control and Prevention 300
Not applicableStudy completedNCT04928456
What this trial is testing

Augmentation of Immune Response to COVID-19 mRNA Vaccination Through OMT With Lymphatic Pumps

Who this might be right for
Covid19
Western University of Health Sciences 92
Not applicableWithdrawnNCT04542395
What this trial is testing

COVID-2019 Testing and Vaccination Among African American and Latinx Public Housing Residents

Who this might be right for
Coronavirus
Charles Drew University of Medicine and Science
Not applicableStudy completedNCT04893265
What this trial is testing

Getting Asian Americans INFORMED to Facilitate COVID-19 Testing and Vaccination

Who this might be right for
Educational Activities
University of California, San Francisco 247
Not applicableUnknownNCT04900467
What this trial is testing

Compare Immunological Efficacy of a Vaccine Regimen Combining Two Covid19 mRNA Vaccines (Pfizer-BioNTech and Moderna) With That of a Homologous Vaccination of Each Covid19 mRNA Vaccine

Who this might be right for
Adult Who Received a First Dose of an mRNA Vaccine (Pfizer-BioNTech or Moderna) and Need to Receive a Second Dose
Assistance Publique - Hôpitaux de Paris 418
Large-scale testing (Phase 3)UnknownNCT05636319
What this trial is testing

Evaluate the Efficacy, Safety, and Immunogenicity of SARS-CoV-2 Variant (BA.4 /5) mRNA Vaccine

Who this might be right for
COVID-19
Suzhou Abogen Biosciences Co., Ltd. 14,168
Not applicableStudy completedNCT05669677
What this trial is testing

Study to Determine the Response to COVID-19 Vaccination and Prevalence of COVID-19 in Subjects With Chronic Liver Disease

Who this might be right for
Chronic or Recovered Hepatitis BChronic or Recovered Hepatitis CChronic or Recovered Hepatitis D+2 more
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 233
Early research (Phase 1)Study completedNCT05743335
What this trial is testing

Assess the Safety and Immunogenicity of JCXH-221, an MRNA-based Broadly Protective COVID-19 Vaccine

Who this might be right for
COVID-19Infectious Disease
Immorna Biotherapeutics, Inc. 73
Not applicableStudy completedNCT04800146
What this trial is testing

A Study on the Immune-response to COVID-19 Vaccination in Cancer Patients - the IOSI-COVID-19-001 Study

Who this might be right for
Covid19Cancer
Ilaria Colombo 177
Large-scale testing (Phase 3)Study completedNCT05299359
What this trial is testing

A Single Heterologous Booster Vaccination Study of TAK-019 in Healthy Japanese Adults (COVID-19)

Who this might be right for
Coronavirus Disease (COVID-19)
Takeda 150
Next Page